These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 31492910)
1. Integrating SpyCatcher/SpyTag covalent fusion technology into phage display workflows for rapid antibody discovery. Fierle JK; Abram-Saliba J; Brioschi M; deTiani M; Coukos G; Dunn SM Sci Rep; 2019 Sep; 9(1):12815. PubMed ID: 31492910 [TBL] [Abstract][Full Text] [Related]
2. Development and Characterization of A Novel SpyTagged Modular Nanobody as A Detection Platform for CD22-Positive Cells. Maali A; Abdoli S; Habibi-Anbouhi M; Noei A; Kadkhodazadeh M; Motamedirad M; Arashkia A; Sharifzadeh Z Cell J; 2024 Oct; 26(8):487-495. PubMed ID: 39380479 [TBL] [Abstract][Full Text] [Related]
3. SpyDisplay: A versatile phage display selection system using SpyTag/SpyCatcher technology. Kellmann SJ; Hentrich C; Putyrski M; Hanuschka H; Cavada M; Knappik A; Ylera F MAbs; 2023; 15(1):2177978. PubMed ID: 36803166 [TBL] [Abstract][Full Text] [Related]
4. A novel synthetic trivalent single chain variable fragment (tri-scFv) construction platform based on the SpyTag/SpyCatcher protein ligase system. Alam MK; Brabant M; Viswas RS; Barreto K; Fonge H; Ronald Geyer C BMC Biotechnol; 2018 Sep; 18(1):55. PubMed ID: 30200951 [TBL] [Abstract][Full Text] [Related]
5. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2). Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047 [TBL] [Abstract][Full Text] [Related]
6. Selection of Antibody Fragments for CAR-T Cell Therapy from Phage Display Libraries. Leyton-Castro NF; Brigido MM; Maranhão AQ Methods Mol Biol; 2020; 2086():13-26. PubMed ID: 31707665 [TBL] [Abstract][Full Text] [Related]
7. BLI-Based Functional Assay in Phage Display Benefits the Development of a PD-L1-Targeting Therapeutic Antibody. Choi JR; Kim MJ; Tae N; Wi TM; Kim SH; Lee ES; Kim DH Viruses; 2020 Jun; 12(6):. PubMed ID: 32630442 [TBL] [Abstract][Full Text] [Related]
8. Generation of human and rabbit recombinant antibodies for the detection of Zearalenone by phage display antibody technology. Sompunga P; Pruksametanan N; Rangnoi K; Choowongkomon K; Yamabhai M Talanta; 2019 Aug; 201():397-405. PubMed ID: 31122440 [TBL] [Abstract][Full Text] [Related]
9. Antibody Phage Display. Shim H Adv Exp Med Biol; 2017; 1053():21-34. PubMed ID: 29549633 [TBL] [Abstract][Full Text] [Related]
10. Selection of single chain antibody fragments binding to the extracellular domain of 4-1BB receptor by phage display technology. Bagheri S; Yousefi M; Safaie Qamsari E; Riazi-Rad F; Abolhassani M; Younesi V; Dorostkar R; Movassaghpour AA; Sharifzadeh Z Tumour Biol; 2017 Mar; 39(3):1010428317695924. PubMed ID: 28347235 [TBL] [Abstract][Full Text] [Related]
12. Selection of potential therapeutic human single-chain Fv antibodies against cholecystokinin-B/gastrin receptor by phage display technology. Tohidkia MR; Asadi F; Barar J; Omidi Y BioDrugs; 2013 Feb; 27(1):55-67. PubMed ID: 23344946 [TBL] [Abstract][Full Text] [Related]
13. The use of phage display to generate conformation-sensor recombinant antibodies. Haque A; Tonks NK Nat Protoc; 2012 Dec; 7(12):2127-43. PubMed ID: 23154784 [TBL] [Abstract][Full Text] [Related]
14. Selection and characterization of human serum albumin-specific porcine scFv antibodies using a phage display library. Muraoka J; Ozawa T; Enomoto Y; Kiyose N; Imamura A; Arima K; Nakayama H; Ito Y Monoclon Antib Immunodiagn Immunother; 2014 Feb; 33(1):42-8. PubMed ID: 24555936 [TBL] [Abstract][Full Text] [Related]
15. Selection of Vaccinia Virus-Neutralizing Antibody from a Phage-Display Human-Antibody Library. Shin YW; Chang KH; Hong GW; Yeo SG; Jee Y; Kim JH; Oh MD; Cho DH; Kim SH J Microbiol Biotechnol; 2019 Apr; 29(4):651-657. PubMed ID: 30856707 [TBL] [Abstract][Full Text] [Related]
16. Dual display: phage selection driven by co-engagement of two targets by two different antibody fragments. Fagète S; Botas-Perez L; Rossito-Borlat I; Adea K; Gueneau F; Ravn U; Rousseau F; Kosco-Vilbois M; Fischer N; Hartley O Protein Eng Des Sel; 2017 Sep; 30(9):575-582. PubMed ID: 28444391 [TBL] [Abstract][Full Text] [Related]
17. Production of human single-chain fragment antibody (ScFv) against human epidermal growth factor receptor-2 (HER-2) by phage display technology. Foroumadi S; Rajabibazl M; Rahimpour A; Shahidi S; Ebrahimizadeh W; Yarahmadi M; Rajabi S; Daraei A In Vitro Cell Dev Biol Anim; 2018 Feb; 54(2):85-91. PubMed ID: 29305748 [TBL] [Abstract][Full Text] [Related]
18. Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes. Rossant CJ; Carroll D; Huang L; Elvin J; Neal F; Walker E; Benschop JJ; Kim EE; Barry ST; Vaughan TJ MAbs; 2014; 6(6):1425-38. PubMed ID: 25484064 [TBL] [Abstract][Full Text] [Related]
19. Selection of scFv Antibody Fragments Binding to Human Blood versus Lymphatic Endothelial Surface Antigens by Direct Cell Phage Display. Keller T; Kalt R; Raab I; Schachner H; Mayrhofer C; Kerjaschki D; Hantusch B PLoS One; 2015; 10(5):e0127169. PubMed ID: 25993332 [TBL] [Abstract][Full Text] [Related]
20. Highly efficient selection of phage antibodies mediated by display of antigen as Lpp-OmpA' fusions on live bacteria. Benhar I; Azriel R; Nahary L; Shaky S; Berdichevsky Y; Tamarkin A; Wels W J Mol Biol; 2000 Aug; 301(4):893-904. PubMed ID: 10966794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]